Nitroglycerin Shortage Expected to Ease Soon — Physician’s First Watch
Nitroglycerin Shortage Expected to Ease Soon
By Kelly Young
A shortage of injectable nitroglycerin — a staple in emergency care for patients with severe heart attacks or congestive heart failure — is expected to ease within the coming weeks, the New York Times reports.
Baxter, one of the drug's manufacturers, was not able to handle increased demand after two other manufacturers stopped producing nitroglycerin. Baxter has had to limit shipments since January, restricting hospitals to 40% of their usual orders. In March, orders were cut even further, to 20%.
Baxter said it expects to return to January shipping levels by the end of this week. Meanwhile, the FDA has sought out overseas suppliers.